0517-2901Level 3
Gvoke VialDx (glucagon injection)
**Product type:** Human Prescription Drug
**Active ingredient:** GLUCAGON
**Strength:** 1 mg/.2mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** American Regent, Inc.
**Marketing category:** NDA (NDA212097)
**Pharmacologic class:** Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]
GET
/api/v1/systems/ndc_fda/nodes/0517-2901Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.